// App-Quantinova.ai

OP0229 (2021) : THE GROUP FOR RESEARCH AND ASSESSMENT OF PSORIASIS AND PSORIATIC ARTHRITIS (GRAPPA) TREATMENT RECOMMENDATIONS 2021

Researchers

Presenter

  • L. C. Coates

Principal Investigators

  • N. Corp

  • H. Bertheussen

  • J. Chau

  • L. Eder

  • D. Fernandez

  • O. Fitzgerald

  • A. Garg

  • D. D. Gladman

  • N. Goel

  • S. Grieb

  • P. Helliwell

  • M. E. Husni

  • D. Jadon

  • A. Katz

  • Y. Y. Leung

  • C. Lindsay

  • E. Lubrano

  • L. Mazzuoccolo

  • P. J. Mease

  • D. Osullivan

  • A. Ogdie

  • W. Olsder

  • L. Schick

  • I. Steinkoenig

  • M. De Wit

  • A. Kavanaugh

Medical Centers

  • University of Oxford, Oxford, United Kingdom

  • Hospital Italiano de Buenos Aires, Servicio de Reumatología, Buenos Aires, Argentina

  • Keele University, School for Primary, Community and Social Care, Stoke on Trent, United Kingdom

  • GRAPPA, Patient Research Partner, Oslo, Norway

  • University of Utah - Salt Lake City - United States of America

  • Santa Casa de Sao Paulo, Rheumatology, Sao Paulo, Brazil

  • GRAPPA, Patient Research Partner, Hong Kong, Hong Kong (SAR)

  • University of Toronto, Rheumatology, Toronto, Canada

  • ospital Universitario San Ignacio, Bogota, Colombia

  • Trinity College Dublin, Rheumatology, Dublin, Ireland

  • Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Dermatology, Hempstead, United States of America

  • Toronto Western Hospital, Schroeder Arthritis Institute, Toronto, Canada

  • GRAPPA, Patient Research Partner, Durham, United States of America

  • GRAPPA, Patient Research Partner, Connecticut, United States of America

  • Rheumatology, Leeds Institute of Rheumatology and Musculoskeletal Medicine, Leeds, United Kingdom

  • Cleveland Clinic Main Campus, Rheumatology, Cleveland, United States of America

  • University of Cambridge, Cambridge, United Kingdom

  • GRAPPA, Patient Research Partner, Haifa, Israel

  • Churchill Hospital, Oxford, United Kingdom

  • GRAPPA, Patient Research Partner, Connecticut, United States of America

  • Singapore General Hospital, Singapore, Singapore

  • GRAPPA, Patient Research Partner, Connecticut, United States of America

  • University of Molise, Psychiatry, Campobasso, Italy

  • Hospital Aleman de Buenos Aires, Buenos Aires, Argentina

  • GRAPPA, Patient Research Partner, Toronto, Canada

  • UCSF Medical Center, Rheumatology, San Francisco, United States of America

  • University of Washington - Seattle - United States of America

  • Patient Research Partner, Dublin, Ireland

  • University of Pennsylvania, Philadelphia, United States of America

  • GRAPPA, Patient Research Partner, Eindhoven, Netherlands

  • GRAPPA, Patient Research Partner, Connecticut, United States of America

  • EULAR Patient Research Partner, Amsterdam, Netherlands

  • Keele University, School for Primary, Community and Social Care, Stoke on Trent, United Kingdom

  • University of California, San Diego, Rheumatology, La Jolla, United States of America

Locations

  • United Kingdom

  • Argentina

  • Norway

  • United States

  • Brazil

  • Hong Kong

  • Canada

  • Colombia

  • Ireland

  • Israel

  • Singapore

  • Italy

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Musculoskeletal

  • Dermatology

  • Ophthalmology (OP)

Disease

  • Psoriatic arthritis

  • Dactylitis

  • Inflammatory Arthritis

  • Psoriasis

  • Uveitis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Abbvie

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved